Atlas Trials

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Clinical trial NCT00294788 · UNKNOWN

Trial details

NCT number
NCT00294788
Sponsor
Probiomics Ltd
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2006-03-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.